Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Ovis has demonstrated a consistent performance in the Capsules category in Alberta. Over the months from July to October 2025, the brand maintained its presence within the top 15 ranks, showing a slight improvement from rank 11 in July and September to rank 10 in August and October. This stability in rankings suggests a steady demand for Ovis capsules in the province, despite a dip in sales in September. The sales figures reveal a notable recovery in October, indicating a positive trend and potential growth momentum in the Alberta market.
However, Ovis's performance in other states and categories is less visible, as the brand does not appear in the top 30 rankings outside of Alberta's Capsules category. This absence might point to either a lack of market penetration or competitive challenges in those regions and categories. The brand's ability to maintain its position in Alberta could serve as a strategic advantage if it can leverage this success to expand its presence in other markets. Understanding the factors that contribute to Ovis's success in Alberta could provide insights into potential areas for growth in other states and categories.
Competitive Landscape
In the Alberta cannabis capsules market, Ovis has shown a notable shift in its competitive positioning over the past few months. Starting from July 2025, Ovis was ranked 11th, but it managed to climb to the 10th position by August, maintaining this rank through October. This upward movement indicates a positive trend in its market presence, especially as it surpassed Dosecann, which fluctuated between the 10th and 11th positions during the same period. Despite this progress, Ovis remains behind Indiva and Leisure Club, which consistently held higher ranks, with Leisure Club even improving its position from 6th to 7th in October. The sales trajectory for Ovis shows a recovery from a dip in September, suggesting a potential for further growth if this momentum continues. This competitive landscape highlights the dynamic nature of the market and underscores the importance of strategic positioning for Ovis to enhance its rank and sales further.

Notable Products
In October 2025, the top-performing product for Ovis was the Blue THC Softgel 15-Pack (150mg) in the Capsules category, maintaining its first-place ranking from previous months with a notable sales figure of 732 units. The CBG/CBD/THC 1:1:1 Softgels 15-Pack (75mg CBG, 75mg CBD, 75mg THC) climbed to second place, improving from its consistent third-place position in prior months. Blue THC Softgel 50-Pack (125mg) fell to third place, showing a decline in sales performance compared to earlier months. The CBD Softgels 30-Pack (1500mg CBD) held steady in fourth place, with a significant increase in sales from September to October. Lastly, the CBD:THC 50:5 Softgels 15-Pack (750mg CBD, 75mg THC) remained in fifth place, showing minimal change in sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







